GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Trade Payables History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Trade Payables | ₹834 Cr | ₹820 Cr | ₹768 Cr | ₹587 Cr | ₹463 Cr |
What is the latest Trade Payables ratio of GLAND PHARMA ?
| Year | Trade Payables |
|---|---|
| Mar2026 | ₹834 Cr |
| Mar2025 | ₹820 Cr |
| Mar2024 | ₹768 Cr |
| Mar2023 | ₹587 Cr |
| Mar2022 | ₹463 Cr |
How is Trade Payables of GLAND PHARMA Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2026 | ₹834 Cr | 1.64 | |
| Mar2025 | ₹820 Cr | 6.86 | |
| Mar2024 | ₹768 Cr | 30.71 | |
| Mar2023 | ₹587 Cr | 26.90 | |
| Mar2022 | ₹463 Cr | - | |
Compare Trade Payables of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹42,525.5 Cr | 6.2% | 4.8% | 24.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 6.2% |
4.8% |
24.3% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses